He Gives Best By Investing: Lawrence Ellison
(2 of 2)
One of his biotech start-ups, a for-profit company called Quark based in Israel, is on the verge of what Ellison says will be a major breakthrough in cancer therapy, one that allows patients to endure higher doses of chemotherapy and radiation without collateral damage to healthy cells. He vows that Quark will be commencing clinical trials shortly. Not coincidentally, he says the company will be going public sometime this year, which will enrich Ellison even further, all the while doing the world a world of good. "The for-profit model is the most efficacious in terms of medical breakthroughs," he says. When pressed, he vows to fund out of his own pocket new cancer therapies for some patients who can't afford them.
"Why do I do this?" he asks, ready with his own answer. "It's a strategy for happiness. If you're on the road for self-esteem, it's not about accumulating as much money as possible. The best way to be happy is to help someone else." And the best way to help, he thinks--echoing Adam Smith--is by making virtue profitable.
- « PREV PAGE
- 1
- 2
Most Popular »
- Good and Bad News for Boxing: Only One Pacquiao
- Five Things the U.S. Can Learn from China
- The Meaning and Mythos of Manny Pacquiao
- How a Bank Robber Became an Antihero in France
- Prosecuting Mohammed: Harder Than You Think
- Does Mexico City Need a Red-Light District?
- Why Does the U.S. Want to Seize Mosques?
- Why We Shouldn't Give Christmas Gifts
- 2012: End-of-World Disaster Porn
- Happiness Paradox: Why Are Americans So Cheery?
- Five Things the U.S. Can Learn from China
- Happiness Paradox: Why Are Americans So Cheery?
- Good and Bad News for Boxing: Only One Pacquiao
- The Meaning and Mythos of Manny Pacquiao
- How a Bank Robber Became an Antihero in France
- New York City: 10 Things to Do in 24 Hours
- Why We Shouldn't Give Christmas Gifts
- Did a Time-Traveling Bird Sabotage the Collider?
- Why Does the U.S. Want to Seize Mosques?
- Now It's Official: There Is Water on the Moon







RSS